AU749365B2 - Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract - Google Patents

Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract Download PDF

Info

Publication number
AU749365B2
AU749365B2 AU51826/98A AU5182698A AU749365B2 AU 749365 B2 AU749365 B2 AU 749365B2 AU 51826/98 A AU51826/98 A AU 51826/98A AU 5182698 A AU5182698 A AU 5182698A AU 749365 B2 AU749365 B2 AU 749365B2
Authority
AU
Australia
Prior art keywords
composition
energy
casein
tgf
lipid source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU51826/98A
Other languages
English (en)
Other versions
AU5182698A (en
Inventor
Franck Arnaud-Battandier
Etienne Grasset
Veronique Jaussan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of AU5182698A publication Critical patent/AU5182698A/en
Application granted granted Critical
Publication of AU749365B2 publication Critical patent/AU749365B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU51826/98A 1997-01-14 1998-01-12 Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract Ceased AU749365B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200096 1997-01-14
EP97200096 1997-01-14

Publications (2)

Publication Number Publication Date
AU5182698A AU5182698A (en) 1998-07-16
AU749365B2 true AU749365B2 (en) 2002-06-27

Family

ID=8227929

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51826/98A Ceased AU749365B2 (en) 1997-01-14 1998-01-12 Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract

Country Status (4)

Country Link
US (1) US5952295A (enExample)
JP (2) JPH10203996A (enExample)
AU (1) AU749365B2 (enExample)
CA (1) CA2223198A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034704A1 (en) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US6210701B1 (en) * 1999-04-30 2001-04-03 Healthcomm International, Inc. Medical food for treating inflammation-related diseases
JP2004527501A (ja) 2001-03-05 2004-09-09 ピー． アーネスト，スティーヴン 経腸処方
WO2002083164A2 (en) * 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
AU2003299568B2 (en) 2002-11-27 2010-07-22 Ampio Pharmaceuticals, Inc. Treatment of diseases and conditions mediated by increased phosphorylation
TR201907898T4 (tr) * 2003-01-31 2019-06-21 Dsm Ip Assets Bv Karotenoidler içeren yeni bileşimler.
JP2006521810A (ja) * 2003-03-11 2006-09-28 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための新規組成物と方法
US7875291B1 (en) 2003-09-05 2011-01-25 Glu-Pro, Inc. Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
WO2005039318A1 (en) * 2003-10-16 2005-05-06 Nestec S.A. Nutritional composition against side effects of chemotherapy of radiotherapy
US7763257B2 (en) * 2004-12-09 2010-07-27 Christina Juneau Compositions comprising transforming growth factor (TGF)-β1 and TGF-β2 in admixture of proteins obtained from dairy products
US20060127493A1 (en) * 2004-12-09 2006-06-15 Yves Pouliot Composition for treating psoriasis
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
PL1800675T4 (pl) * 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
US20090186034A1 (en) * 2006-12-19 2009-07-23 Genetech, Inc. Gene expression markers for inflammatory bowel disease
JP2011509071A (ja) 2007-11-29 2011-03-24 ジェネンテック， インコーポレイテッド 炎症性腸疾患のための遺伝子発現マーカー
US8350006B2 (en) * 2008-10-24 2013-01-08 Mead Johnson Nutrition Company Methods for determining the bioactivity of TGF-β in a composition
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8367354B2 (en) * 2008-10-24 2013-02-05 Mead Johnson Nutrition Company Methods for determining the levels of TGF-β in a composition
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
EP2757160A3 (en) 2009-07-20 2014-07-30 Genentech, Inc. Gene expression markers for Crohn's disease
EP2311486A1 (en) * 2009-10-07 2011-04-20 Nestec S.A. GLP-2 for use in intestine and muscle recovery
WO2012071436A1 (en) 2010-11-24 2012-05-31 Genentech, Inc. Method of treating autoimmune inflammatory disorders using il-23r loss-of-function mutants
US20120171328A1 (en) * 2011-01-05 2012-07-05 Dattatreya Banavara Composition comprising heat labile milk proteins and process for preparing same
US20210176999A1 (en) 2011-04-17 2021-06-17 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
CA2877811C (en) * 2012-07-31 2019-07-23 Nestec S.A. Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (ibd)
EP3212198B1 (en) 2014-10-29 2020-12-23 Glycom A/S Synthetic composition and method for promoting mucosal healing
IT201900008394A1 (it) * 2019-06-07 2020-12-07 Sofar Spa Composizione per uso nel trattamento delle malattie infiammatorie croniche intestinali

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0527283A1 (en) * 1991-08-12 1993-02-17 Societe Des Produits Nestle S.A. Food composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60203172A (ja) * 1984-03-29 1985-10-14 Sanwa Kagaku Kenkyusho:Kk 経口・経管栄養食
GB8723094D0 (en) * 1987-10-01 1987-11-04 Ciba Geigy Ag Polypeptide growth factor from milk
JP3102645B2 (ja) * 1990-10-15 2000-10-23 雪印乳業株式会社 栄養補給用栄養組成物
US5661123A (en) * 1995-01-17 1997-08-26 Nestec, Ltd. Enteral composition for malabsorbing patients

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0527283A1 (en) * 1991-08-12 1993-02-17 Societe Des Produits Nestle S.A. Food composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BEATTIE R.M. ET AL ('94) ALIMENT. PHARMACOL. THER. 8(6):609-615 *

Also Published As

Publication number Publication date
JPH10203996A (ja) 1998-08-04
AU5182698A (en) 1998-07-16
CA2223198A1 (en) 1998-07-14
JP2010100655A (ja) 2010-05-06
US5952295A (en) 1999-09-14

Similar Documents

Publication Publication Date Title
AU749365B2 (en) Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
JP2010100655A6 (ja) 炎症状態にある胃腸管の治療用組成物とその方法
US9763898B2 (en) Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (IBD)
JP5574561B2 (ja) 総合経腸栄養組成物
JPH11508282A (ja) 悪液質および食欲不振の予防および治療方法
CN101472578A (zh) 孕妇补充剂
WO2008147562A2 (en) Dietary formulations and methods for treatment of inflammation and other disorders
EP0852913A1 (en) Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
CA2399063C (en) A method for maintaining or improving the synthesis of mucins
Kelly Nutrition in inflammatory bowel disease
US6833350B2 (en) Method for maintaining or improving the synthesis of mucins
US20090137459A1 (en) Food Product for Enteral or Oral Nutrition
US5670157A (en) Method for reducing and controlling immunoglobulin concentrations
Brown et al. Nonlipid formula components and fat absorption in the low-birth-weight newborn
da Silva et al. Nutrition in Inflammatory Bowel Disease
de Jong et al. P. 101 Biosynthesis of cholesterol and 7-dehydrocholesterol in Smith-Lemli-Opitz (SLO) fibroblasts measured by gas chromatography-mass spectrometry (GCMS)
HK1064026A (en) Nutritional composition for the prevention and treatment of cachexia and anorexia
HK1019857B (en) Prevention and treatment of cachexia and anorexia
HK1209984B (en) Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (ibd)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)